These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7888983)

  • 1. Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.
    Naranjo CA; Bremner KE; Lanctôt KL
    Addiction; 1995 Jan; 90(1):87-99. PubMed ID: 7888983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine attenuates alcohol intake and desire to drink.
    Naranjo CA; Poulos CX; Bremner KE; Lanctot KL
    Int Clin Psychopharmacol; 1994 Sep; 9(3):163-72. PubMed ID: 7814825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.
    Naranjo CA; Poulos CX; Bremner KE; Lanctôt KL
    Clin Pharmacol Ther; 1992 Jun; 51(6):729-39. PubMed ID: 1535302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.
    Naranjo CA; Poulos CX; Lanctôt KL; Bremner KE; Kwok M; Umana M
    Addiction; 1995 Jul; 90(7):893-905. PubMed ID: 7663312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of citalopram on alcohol intake in heavy drinkers.
    Balldin J; Berggren U; Engel J; Eriksson M; Hård E; Söderpalm B
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1133-6. PubMed ID: 7847595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics.
    Naranjo CA; Kadlec KE; Sanhueza P; Woodley-Remus D; Sellers EM
    Clin Pharmacol Ther; 1991 Jul; 50(1):96-106. PubMed ID: 1855357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of alcohol consumption across the drinking career in alcoholics and social drinkers.
    York JL
    J Stud Alcohol; 1995 May; 56(3):328-36. PubMed ID: 7623472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using fuzzy logic to predict response to citalopram in alcohol dependence.
    Naranjo CA; Bremner KE; Bazoon M; Turksen IB
    Clin Pharmacol Ther; 1997 Aug; 62(2):209-24. PubMed ID: 9284858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
    Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.
    Heffner JL; Tran GQ; Johnson CS; Barrett SW; Blom TJ; Thompson RD; Anthenelli RM
    J Stud Alcohol Drugs; 2010 Jan; 71(1):61-70. PubMed ID: 20105415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does participation in an alcohol administration study increase risk for excessive drinking?
    Pratt WM; Davidson D
    Alcohol; 2005 Nov; 37(3):135-41. PubMed ID: 16713501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluoxetine on alcohol consumption in male alcoholics.
    Gorelick DA; Paredes A
    Alcohol Clin Exp Res; 1992 Apr; 16(2):261-5. PubMed ID: 1317133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
    O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
    J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin uptake inhibitor citalopram attenuates ethanol intake.
    Naranjo CA; Sellers EM; Sullivan JT; Woodley DV; Kadlec K; Sykora K
    Clin Pharmacol Ther; 1987 Mar; 41(3):266-74. PubMed ID: 3469057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in response to citalopram in men and women with alcohol dependence.
    Naranjo CA; Knoke DM; Bremner KE
    J Psychiatry Neurosci; 2000 May; 25(3):269-75. PubMed ID: 10863887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
    Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance among heavy alcohol users in clinical drug trials.
    Sullivan JT; Naranjo CA; Sellers EM
    J Subst Abuse; 1988-1989; 1(2):183-94. PubMed ID: 2980999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the TWEAK test in screening for alcoholism/heavy drinking in three populations.
    Chan AW; Pristach EA; Welte JW; Russell M
    Alcohol Clin Exp Res; 1993 Dec; 17(6):1188-92. PubMed ID: 8116829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcoholic subtypes and the MacAndrew Alcoholism Scale.
    Svanum S; Ehrmann LC
    J Pers Assess; 1992 Apr; 58(2):411-22. PubMed ID: 1578334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of angiotensin II synthesis inhibition on alcohol consumption].
    Guivernau M; Pallavicini J
    Rev Med Chil; 2008 Aug; 136(8):968-75. PubMed ID: 18949179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.